Bottom line
What is ICEVX's expense ratio?
ICEVX's expense ratio is 1.1%, or about $110 a year on every $10,000 invested. That is more expensive than 68% of international stock funds we track (median 0.9%). This share class also charges a front-end sales load of up to 5.5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Oct 8, 2026
ICEVX fee table
| Net expense ratio | 1.1% |
|---|---|
| Gross expense ratio | 1.1% |
| Management fee | 0.7% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.15% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 5.5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 8, 2026
What ICEVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| ICEVX | $666 | $910 | $1,173 | $1,925 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.1% expense ratio costs roughly $60,400 in lost growth, versus about $50,300 for the median international stock fund (0.9%).